Aurobindo Pharma Ltd. | AUROPHARMA | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  |  Income Statement  |  Cash Flow  |  Quarterly

Financial Summary Report of Aurobindo Pharma Ltd.



AUROPHARMA
Aurobindo Pharma Ltd.

Rs. 474.30
20-Mar-2023

5 Yr Performance

1 Yr Performance

Valuation

Quarterly

Earnings Yield



Analysis


Upgrade to Professional Membership

Quarterly Revenue, Net Income and Adjusted Share Price



Upgrade to Professional Membership

Peer Comparison


AstraZenca Pharma India Ltd.

Biocon Ltd.

Cadila Healthcare Ltd.

Cipla Ltd.

RPG Life Sciences Limited

Divis Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

FDC Ltd.

Fresenius Kabi Oncology Ltd.

Glaxosmithkline Pharmaceuticals Ltd.